Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rigel Pharmaceuticals

18.28
-0.0100-0.05%
Volume:221.19K
Turnover:4.03M
Market Cap:326.71M
PE:8.77
High:18.69
Open:18.29
Low:17.95
Close:18.29
Loading ...

Rigel Pharmaceuticals Is Maintained at Neutral by Cantor Fitzgerald

Dow Jones
·
07 May

Rigel Pharma Jump 9.9% Premarket; Guides 'Positive' Net Income in 2025 After Swinging to Profit in Q1

MT Newswires Live
·
07 May

Rigel Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Rigel Pharmaceuticals Q1 EPS $0.63 Beats $0.09 Estimate, Sales $53.30M Beat $43.87M Estimate

Benzinga
·
07 May

BRIEF-Rigel Pharmaceuticals Q1 EPS USD 0.64 Vs. IBES Estimate USD 0.02

Reuters
·
07 May

Rigel Pharmaceuticals Inc - Projects 2025 Revenue of $200-$210 Million

THOMSON REUTERS
·
07 May

Rigel Pharmaceuticals Inc expected to post earnings of 2 cents a share - Earnings Preview

Reuters
·
03 May

Rigel Announces Conference Call and Webcast to Report First Quarter 2025 Financial Results and Business Update

PR Newswire
·
29 Apr

Rigel (RIGL) Upgraded to Buy: What Does It Mean for the Stock?

Zacks
·
18 Apr

4 Healthcare Stocks to Buy as the Sector Faces Government Heat

Zacks
·
17 Apr

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

PR Newswire
·
04 Apr

High Growth Tech Stocks in the US for April 2025

Simply Wall St.
·
04 Apr

BUZZ-Rigel climbs on blood disorder drug patent settlement

Reuters
·
27 Mar

Rigel Pharmaceuticals Settles Patent Litigation Over Tavalisse

MT Newswires Live
·
27 Mar

BRIEF-Rigel Announces Settlement Agreement Resolving TAVALISSE® (Fostamatinib Disodium Hexahydrate) Patent Litigation

Reuters
·
27 Mar

Rigel Pharmaceuticals Inc - Under Settlement, Annora to Sell Generic Tavalisse in Q2 2032 or Earlier

THOMSON REUTERS
·
27 Mar

Rigel Pharmaceuticals Inc - Co and Annora Terminate All Ongoing Litigation Regarding Tavalisse Patents

THOMSON REUTERS
·
27 Mar

Rigel Announces Settlement Agreement Resolving Tavalisse® (Fostamatinib Disodium Hexahydrate) Patent Litigation

THOMSON REUTERS
·
27 Mar

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation

PR Newswire
·
27 Mar

Rigel Pharmaceuticals Appoints Dr. Frohlich to Board

TIPRANKS
·
11 Mar